Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Dyspnoea; Numbness of lips; itching; swelling; This is a spontaneous report from the contactable physician received from the Regulatory Authority. The Regulatory authority report number is v21111760. The patient was 28-year-old female. Body temperature before the vaccinations was 36.4 degrees centigrade on 03Jun2021. The patient''s history according to the Vaccine Screening Questionnaire was atopy, allergy to shrimp, crab, squid. The patient''s concomitant drug was not provided. On 03Jun2021 at 14:00 (the day of vaccination, at the age of 28-year-old), the patient received the first dose of BNT162B2 (COMIRNATY, Intramuscular injection, Lot number: EY2173, expiration date: 31Aug2021), via an unspecified route of administration as a single dose for COVID-19 immunisation. On 03Jun2021 at 14:05 (the day of vaccination), the patient experienced dyspnoea, numbness of lips, itching. The outcome of the event was recovering on 03Jun2021 (The day of vaccination). Clinical course of the event was reported as follows: The patient experienced dyspnoea, numbness of lips, swelling a few minutes after vaccination. In addition, before vaccination, the patient did not eat meat that can cause allergy. So the relationship assessed as related. After administration of antihistamine, the symptoms was recovering. The reporter classified the event as non-serious and the causality between the event and the vaccines was Related. Other possible cause of the event such as any other diseases was no.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166